Atsushi Miwa

869 citations
33 papers · 734 indexed · h-index 14
Topics
Fibroblast Growth Factor Research (5 papers)Cardiac Ischemia and Reperfusion (5 papers)Nitric Oxide and Endothelin Effects (4 papers)
Partner nations
JapanUnited StatesChina

In The Last Decade

Atsushi Miwa

33 papers receiving 713 citations

Peers

Atsushi Miwa
Comparison fields: 5 of 76
  • Molecular Biology 438
  • Oncology 255
  • Cancer Research 140
  • Pulmonary and Respiratory Medicine 100
  • Pathology and Forensic Medicine 83
Replace Ti Wen with:
Ti Wen China
Anne Mazars France
Kesen Xu China
Yun Hee Kang South Korea
Hubert E. Appert United States
Mark J. Sinnamon United States
Janyaporn Phuchareon United States
Hiroaki Kasashima Japan
Zhenjia Yu China
Tao Pan China
Atsushi Miwa relative to Ti Wen China Ti Wen's profile →
Citations per field
00.5×1.6×
Ti Wen · 1×
Citations per year

Countries citing papers authored by Atsushi Miwa

Since Specialization
Citations

This map shows the geographic impact of Atsushi Miwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Miwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Miwa more than expected).

Fields of papers citing papers by Atsushi Miwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Miwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Miwa. The network helps show where Atsushi Miwa may publish in the future.

Co-authorship network of co-authors of Atsushi Miwa

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Miwa. A scholar is included among the top collaborators of Atsushi Miwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Miwa. Atsushi Miwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 85
3 38
4 82
5 41
6 24
7 9
8 64
9 5
10 42
11 22
12 22
13
Evaluation of PCNA, p53, K-ras and LOH in endocrine pancreas tumors.
8
14 1
15 5
16 22
17 13
18 13
19 4
20 36

About Atsushi Miwa

Atsushi Miwa is a scholar working on Hematology, Oncology and Gastroenterology, having authored 33 papers that have together received 734 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (5 papers), Cardiac Ischemia and Reperfusion (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). The work is most often cited by research in Oncology (255 citations), Cancer Research (140 citations) and Molecular Biology (438 citations). Atsushi Miwa has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Kosei Hirakawa, Masakazu Yashiro, Toshiyuki Shimizu, Osamu Shinto, Kazunori Nakamura, Kiyoshí Shimizu, Tasuku Matsuoka, Masashige Tendo, Tsuyoshi Hasegawa and Junko Matsuoka. Their work appears in journals such as Blood, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026